Efficiency and safety of melatonin receptor agonist for treatment of nocturia

Hirofumi Obata, Ryosuke Takahashi, Masatoshi Eto, Takakazu Yunoki, Toshihisa Tomoda

研究成果: ジャーナルへの寄稿学術誌査読


Purpose: We examined the efficacy of ramelteon for patients with insomnia and nocturia. Methods: Thirteen patients above the age of 50 years who were experiencing both insomnia and two or more nocturnal voids were included in the study. Patients who had polyuria of over 3,000 ml and post residual urine of over 100 ml were excluded. The patients were treated with ramelteon 8 mg for twelve weeks and the degree of lower urinary tract symptoms and sleep disorder was evaluated using the International Prostate Symptom Score (IPSS) and the N-QOL score at pre-treatment, 4 weeks, 8 weeks, and 12 weeks. Results: The mean IPSS score improved significantly from 15.7 ± 1.4 at baseline to 12.8 ± 3.1 at twelve weeks. The subject scores for the number of nocturnal voids also decreased significantly from 3.4 ± 0.2 to 2.5 ± 0.3. N-QOL score also improved significantly from 58.3 ± 12.4 to 68.8 ± 14.1. Conclusions: Ramelteon reduces both nocturia and disturbed sleep in patients with insomnia and nocturia.

ジャーナルNishinihon Journal of Urology
出版ステータス出版済み - 10月 2016

!!!All Science Journal Classification (ASJC) codes

  • 泌尿器学


「Efficiency and safety of melatonin receptor agonist for treatment of nocturia」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。